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Retinoids are involved in several essential processes in mammals,
including vision, morphogenesis, spermatogenesis and maintenan-
ce of epithelial tissue. Since they are labile compounds, nearly in-
soluble in water, they are present in body fluids and within the cell
bound to specific retinoid-binding proteins. In plasma, a single pro-
tein, called retinol-binding protein, delivers the alcoholic form of
vitamin A from its store sites to target cells. In the cytoplasm, four
different cellular retinol-binding proteins and two retinoic acid-
binding proteins have been discovered and structurally characteri-
zed to date. Finally, two classes of nuclear receptors for retinoic
acid isomers have been characterized. The structure/function rela-
tionship for several retinoid-binding proteins is discussed here.
Key words: vitamin A, retinol, retinoids, retinoic acid, retinol-bind-
ing proteins, retinoid receptors, crystal structure.
INTRODUCTION
Retinoids constitute a large group of synthetic and naturally occurring
compounds related to retinol, the vitamin A alcohol (Figure 1). By analogy
with the prototypical retinol molecule, physiologically occurring retinoids
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are characterized by a -ionone ring, a polyene chain and a functional polar
end group. In mammals, retinoids fulfil essential roles and their metabo-
lism, biological effects and mechanism of action are topics of considerable
research interest. Because of their chemical instability and quite low solu-
bility in the uncomplexed form in an aqueous medium, natural retinoids
need to be bound to specific retinoid-binding proteins to be protected, solubi-
lized, and transported in body fluids and within the cell. Retinol circulates
in blood bound to Retinol-binding Protein (RBP), which delivers the vitamin
from its store sites to target cells.1 The homologous Cellular Retinol-binding
Proteins (CRBPs) and Cellular Retinoic Acid-binding Proteins (CRABPs)
have been reported to be cytoplasmic carriers of retinoids.1–3 In addition,
the eye has distinct retinoid-binding proteins, unrelated to RBP and CRBPs/
CRABPs: a Cellular Retinaldehyde-binding Protein and an Interstitial/In-
terphotoreceptor Retinoid-binding Protein. Besides being involved in vision,
a process in which 11-cis-retinal plays a key role, retinoids are indispens-
able for morphogenesis, spermatogenesis and the maintenance of epithelial
tissue. For the last mentioned processes, isomers of retinoic acid have been
shown to be the active vitamin A derivatives. Both 9-cis and all-trans iso-
mers of retinoic acid are transcriptional activators, which exert their effects
through binding to specific nuclear retinoid receptors.4 Finally, evidence has
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Figure 1. Some retinoids cited in the text. (A) all-trans-retinol, (B) all-trans-retinoic
acid, (C) axerophtene, (D) fenretinide.
been obtained that retinoids are involved in the regulation of the immune
response by controlling lymphocyte survival.5
THE PLASMA CARRIER OF RETINOL
Retinol is the prevailing retinoid in blood, and is mainly transported
through the circulation from the storage site richest in vitamin A, the liver,
to the surface receptors of a variety of target cells (Figure 2). This transport
is specifically performed by RBP, a monomeric plasma protein of 21 kDa,
which contains one binding site for retinol and belongs to the superfamily of
extracellular Lipid-binding Proteins (eLBPs or lipocalins).6 RBP circulates
in plasma bound to another plasma protein, transthyretin (TTR). Besides
being involved in the plasma transport of retinol-RBP, TTR is one of the pla-
sma carriers of the thyroid hormone thyroxine. The formation of the RBP-
TTR macromolecular complex is supposed to prevent filtration through re-
nal glomeruli of the relatively small RBP molecule.
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Figure 2. A schematic representation of vitamin A transport from the liver store site
to target cells. The alcoholic form of vitamin A, retinol, is released in plasma bound
to retinol-binding protein (RBP), which in turn forms a complex with another pro-
tein, transthyretin. When the ligand is released to the cell receptor, the complex dis-
sociates and RBP is catabolized in renal glomeruli. Retinol and retinoic acid in the
cell cytoplasm are bound to specific binding proteins, CRBPs and CRABPs (see text
for details).
The crystal structures of human,7,8 bovine,9 pig10 and chicken11 RBPs
have been determined (Figure 3). The RBP polypeptide chain folds into a
single domain, made up of a N-terminal coil, eight antiparallel -strands, a
short -helix and a C-terminal strand. The core of the protein is the internal
cavity of the eight-stranded up-and-down -barrel, where the ligand binds:
the -ionone ring and the polyene chain are completely buried inside the in-
ternal cavity, of a shape highly complementary to that of the ligand, whilst
the alcoholic end group is at the protein surface, in contact with the solvent.
The protein-retinol interactions are essentially hydrophobic, with the
exception of the hydroxyl group, which participates in the hydrogen bond in-
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Figure 3. Plasma retinol-binding protein (RBP). (a) van der Waals representation of
bovine plasma RBP (blue spheres) with retinol bound within the cavity (green sphe-
res, the oxygen atom of OH group in red; coordinates from PDB 1HBP). (b) Cartoon
representation of the same model. (c ) Same as (a), but the model has been cut by a
plane parallel to the paper to make the ligand inside the -barrel cavity more visible.
(d) van der Waals representation of the complex between RBP (yellow) and trans-
thyretin, a tetramer made up of four identical subunits (from red to orange). Coordi-
nates from PDB 1RLB. Only one RBP molecule is shown to represent the physiologi-
cal complex in plasma.
teraction, mediated by a water molecule, with a carbonyl oxygen of the main
chain. The high degree of complementarity between retinol and the ligand-
binding cavity makes the binding very specific, so that chemical modifica-
tions of the retinol skeleton abolish the binding ability. Instead, the posi-
tioning of the terminal portion of the tail of the ligand allows the protein to
easily accommodate the acid or aldehyde form of the vitamin, as well as re-
tinoids bearing bulky end groups, as we have previously shown.12,13 Speci-
fically, the crystal structures of bovine RBP complexed with all-trans-retino-
ic acid, N-(4-hydroxyphenyl)retinamide, N-ethylretinamide and axerophthene
illustrate how analogs of the retinol molecule, modified in correspondence to
its alcoholic end group, still interact effectively with the protein moiety.
The extraction of retinol from the cavity of the holoprotein by using or-
ganic solvents induces minor but significant conformational changes: the
superposition of the models of the apo and holo forms of human7 and bo-
vine8 RBPs shows differences in correspondence of residues 33–36, which
are present in one of the ligand entrance loops. In particular, the side chains
of Leu-35 and Phe-36 change their orientation in the apoprotein and occupy
some of the space left by the vitamin. The rest of the cavity is probably filled
with non-ordered water molecules or with molecules of the organic solvent
used to extract the ligand from the holoprotein.
The molecular mechanism of ligand binding and release for plasma RBP
remains to be clarified. Since the -barrel internal cavity of RBP has the
shape of a calyx, the open end of the calyx is very likely the portal involved
in retinol entering/exiting. Indeed, in agreement with this hypothesis, in the
holoprotein, the retinol hydroxyl group is protruding from the protein sur-
face towards the solvent from this end. However, the crystal structure of the
apoprotein is similar to that of the holoprotein and, as such, does not allow
the retinol molecule to enter. Therefore, it must be assumed that the apo
and holo structures represent similar and static structural situations whe-
reas, during the apo/holo transition, the protein undergoes remarkable li-
gand-dependent conformational changes, accompanying the process of the
binding/release of the vitamin. It has in fact been proposed14 that the pro-
tein molecule is more flexible than what appears from its crystal structure,
and that the release of retinol might require a reversible transition of the
protein to a transient, poorly structured state, perhaps a »molten globule«
state. It has been shown that low pH conditions favor the release of retinol,
along with mild denaturing conditions.14 A molecular hypothesis for this be-
havior has been put forward in the past by this laboratory:15 a number of
conservative, positively charged side chains located on the retinol-binding
face of the RBP molecule are involved in salt bridges with conservative, nega-
tively charged groups. At acidic pH values, close to the pKa value of the aci-
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dic groups, these salt bridges are broken and, consequently, the retinol-
binding face of RBP would hold from 8 to 12 positively charged groups. Such
groups might ensure a proper orientation of the RBP molecule relative to
the negatively charged cell membrane surface. The disruption of salt brid-
ges and the electrostatic repulsion of positive charges might soften the
structure near the entrance of the retinol-binding pocket and trigger the re-
lease of the ligand.
Holo-RBP circulates in plasma bound to another protein, transthyretin
(TTR), forming the ternary retinol-RBP-TTR complex. At present, the crys-
tal structures of two such complexes are available: the heterologous complex
between chicken RBP and human TTR16 and the homologous complex be-
tween human RBP and human TTR.17 In both cases, the highest resolution
of the data is quite limited, about 3.2 Å. The stoichiometry of the complex
involves one TTR and two RBPs (Figure 3). TTR is a symmetric tetramer
and, in both cases, two RBP molecules are bound to it in a symmetric way.
The orientation of the TTR-bound RBP molecules is different in the two
complexes, but this is probably due to a different influence of the crystal
state in the two cases. Recently, we have crystallized the human RBP-TTR
complex associated with an anti-RBP Fab. Despite the very small size of the
crystals, using the synchrotron radiation beamline of Elettra (Trieste, Italy),
a data set to a resolution of 3.2 Å has been obtained.18 The crystals belong
to the C222 space group, with a = 159.3 Å, b = 222.4 Å and c = 121.27 Å. The
structure determination of this macromolecular complex, consisting of three
proteins, is under way in our laboratory.
THE CYTOPLASMIC CARRIERS OF RETINOIDS
A number of in vitro studies have suggested that CRBPs could play im-
portant roles in vitamin A homeostasis, being involved in retinol internali-
zation, retinol esterification and oxidation, and retinyl ester hydrolysis.2,3
Additionally, retinol-CRBP complexes, rather than uncomplexed retinol,
might serve as substrates of enzymes involved in the retinol metabolism.2,3
Despite the wealth of in vitro data obtained with purified proteins and/or
subcellular fractions, the precise functional roles of CRBPs remain to be de-
fined. Similarly to CRBPs, it has been proposed that CRABPs serve to so-
lubilize and protect their ligand in the aqueous cytosol, and that they trans-
port retinoic acid between different cellular compartments. Apart from the
aforementioned intracellular retinoid-binding protein present in the eye, six
cytoplasmic retinoid-binding proteins have been identified in mammals:
four CRBPs, and two CRABPs.2,3,19,20 They are monomeric proteins of ap-
proximately 15 kDa and belong, along with the Fatty Acid Binding Proteins
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(FABPs), to the superfamily of iLBPs (intracellular Lipid Binding Proteins).
The crystal structures of all these proteins are known and, despite a consid-
erable variance in their primary structures, they possess a highly similar
overall three-dimensional structure:1 ten antiparallel -strands form a -bar-
rel with a shell-like shape, closed at one end by a helix-turn-helix motif and
containing within its internal cavity the hydrophobic ligand-binding site
(Figure 4). In the case of CRBPs/CRABPs, the retinoid is completely buried
inside the cavity, so that it is totally isolated from the outside solvent. The
binding of retinol in CRBPs is strongly stabilized by an H-bond interaction
of the hydroxyl group of the vitamin with Gln-108 in CRBP I and II,1,2 and
with His-108 in CRBP III.19 In the case of CRABP, the negatively charged
carboxylate group of the vitamin makes a salt bridge with Arg-131 and
Arg-132 in CRABP I and II, respectively.1 In the cytoplasmic retinoid-bind-
ing proteins, the protein cavity is definitely larger than the ligand and in all
cases several ordered solvent molecules, from seven to nine, are present wi-
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Figure 4. Cartoon representation of some cellular retinol-binding proteins (CRBPs).
(a) holo-CRBP I (coordinates from PDB 1CRB), (b) holo-CRBP II (coordinates from
PDB 1OPB), (c) apo-CRBP II (coordinates from PDB 1OPA), (d) apo-CRBP III (coor-
dinates from PDB 1GGL). These proteins have a globular compact shape, made up of
ten antiparallel -strands and a helix-turn-helix motif.
thin the cavity along with the retinoid. All these water molecules are well
defined in the crystal structures, and form intermolecular hydrogen bonds
as well as hydrogen bonds with the side chains of residues lining the -bar-
rel internal cavity. They may play a structural role and limit, presumably
along with non-ordered water molecules, the volume of the cavity accessible
to the ligand.
Despite the abundance of experimental data available, there are several
open questions about the functional and structural properties of the mem-
bers of the CRBP and CRABP protein families. In particular:
a) To what extent are they specific with regard to ligand binding, the func-
tion displayed and tissue distribution?
b) What is the mechanism of release of the ligand from the interior of the
cavity and of its binding? Because limited conformational differences be-
tween the crystalline holo and apoproteins have been reported, one must
hypothesize that significant, but transient, protein conformational chan-
ges take place to allow ligand binding/release.
c) What is the exact function of different CRBPs and CRABPs, apart from
that obvious of binding the retinoid? Several hypotheses have been put
forward, but none of them seems to be conclusive. Since several proteins
that bind the same retinoid may be present in a particular tissue, it is
likely that they can not simply have the function of binding and solubi-
lizing the ligand. At least some of these proteins must perform more spe-
cialized functions. In particular, it has been proposed that specific recog-
nition properties of CRBPs/CRABPs may allow a specific delivery of reti-
noids to enzyme systems or other acceptors. Recently, the role of CRABP
in shuttling retinoic acid from the cytoplasm to the cell nucleus and the
delivery of this retinoid to retinoic acid receptors has been reported.21
THE NUCLEAR RETINOID RECEPTORS
It is in the nucleus that retinoic acid performs the important function of
regulating gene transcription.4 This action is displayed through the binding
of the retinoid to nuclear receptors, proteins containing several domains,
such as a DNA-binding domain and a ligand-binding domain. Two families
of retinoic acid receptors have been characterized to date: the RARs (reti-
noic acid receptors) and the RXRs (retinoid X receptors). The former bind
all-trans and 9-cis-retinoic acid and the latter bind 9-cis-retinoic acid.
X-ray structures have been determined for the ligand binding domains
of RARs, RXRs and RXRs22–24 and found to be quite similar: twelve -he-
lices form a sort of helical sandwich, in which a layer of -helices and two
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-strands are surrounded by two layers of -helices. The retinoic acid mole-
cule binds in the center of this structure (Figure 5). Significant conforma-
tional changes, presumably associated with the activation of the receptors
to transcription factors, are induced by ligand-binding.
CRYSTAL STRUCTURES OF OTHER
RETINOID-BINDING PROTEINS
A protein that shares a similarity of folding motifs with plasma RBP25 is
epididymal retinoic-acid binding protein (E-RABP), a major secreted protein
found in the lumen of epididymis. Its physiological role is probably that of
supplying the retinoic acid necessary in either sperm maturation or epididy-
mal function. Since E-RABP, differently from RBP, binds retinoic acid, there
are considerable structural differences in the binding sites of the two pro-
teins.
Proteins of the lipocalin family other than RBP are known to bind re-
tinol in vitro, for example -lactoglobulin, a protein found in milk of several
mammals. Nevertheless, vitamin A in the milk is associated with fat glob-
ules, and retinol bound to -lactoglobulin extracted from milk has not been
detected yet.
All-trans-retinol and 11-cis-retinal are known to bind to interphotorecep-
tor retinoid binding protein (IRBP), the major soluble component of inter-
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Figure 5. Cartoon representation of the retinoid binding domain of human RAR-
complexed with all-trans-retinoic acid (coordinates from PDB 2LBD).
photoreceptor matrix. This large protein, made up of four contiguous re-
peats, is critical to the function, integrity, and development of the vertebrate
retina. The crystal structure at 1.8 Å resolution of one of the functional
units of the protein from Xenopus laevis has been recently determined.26
The module consists of two domains, separated by a hydrophobic ligand bin-
ding site, that have not structural similarity with lipocalins.
CONCLUSIONS
Different classes of proteins originate from mammals that bind retinoids
either extracellularly or intracellularly. In plasma, a single protein (RBP)
binds and transports retinol. Its main function is that of solubilizing and
protecting the retinol molecule in plasma and of transporting/delivering it
to the receptors of target cells. In the cytoplasm, at least six different re-
tinoid-binding proteins are present: they share a relatively limited sequence
identity, but represent a very similar structural fold, and they also bind
retinol (CRBPs) or retinoic acid (CRABPs) in a similar fashion. Their func-
tional roles have not been well established yet. Finally, in the nucleus, two
different families of retinoic acid receptors (RARs and RXRs) have been
identified and their function in the control of gene transcription has been
established. The crystal structure of the retinoid binding domain of nuclear
receptors is totally different from those of the extracellular and intracellular
carriers of retinoids, in agreement with the distinct role of nuclear receptors
compared to those of the carrier proteins.
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Retinoidi u sisavaca: kristalografsko gledanje
Giuseppe Zanotti i Rodolfo Berni
U sisavaca retinoidi sudjeluju u nekoliko bitnih procesa koji uklju~uju vid, mor-
fogenezu, spermatogenezu i odr`avanje epitelnih tkiva. Oni su prisutni u tjelesnim
teku}inama, a u stanici su vezani na specifi~ne retinoid-ve`u}e proteine, jer su la-
bilni spojevi skoro netopivi u vodi. U plazmi jedan jedini protein, nazvan retinol-ve-
`u}i protein, isporu~uje alkoholni oblik vitamina A iz njegovih mjesta skladi{tenja u
ciljne stanice. U citoplazmi su do sada otkrivena i strukturno okarakterizirana ~etiri
razli~ita retinol-ve`u}a proteina i dva proteina koji ve`u retinsku kiselinu. Kona~no,
okarakterizirane su dvije klase nuklearnih receptora za izomere retinske kiseline.
Ovdje se raspravlja odnos strukture i funkcije za nekoliko retinoid-ve`u}ih proteina.
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